Increased oxidative stress is responsible for severer cerebral infarction in stroke-prone spontaneously hypertensive rats

CNS Neuroscience and Therapeutics

Volumn 17, Issue 6, 2011, Pages 590-598

  Zhang, Xiu Hua ^a   Lei, Hong ^a   Liu, Ai Jun ^a   Zou, Ying Xin ^a   Shen, Fu Ming ^a   Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Oxidative stress; Pathogenesis; Spontaneously hypertensive rats; Stroke; Stroke prone spontaneously hypertensive rats; Two dimensional fluorescent difference gel electrophoresis

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE A5; GLUTATHIONE TRANSFERASE P1; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; STROKE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ALDEHYDES; AMINO ACID SEQUENCE; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOTTING, WESTERN; CEREBRAL INFARCTION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLUTATHIONE PEROXIDASE; IMAGE PROCESSING, COMPUTER-ASSISTED; INFARCTION, MIDDLE CEREBRAL ARTERY; LIPID PEROXIDATION; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; STROKE; VITAMIN E; VITAMINS;

EID: 82355191894     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2011.00271.x     Document Type: Article

References (45)

1. Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology 2008;55:310-318.
2. Flynn RW, MacWalter RS, Doney AS. The cost of cerebral ischaemia. Neuropharmacology 2008;55:250-256.
3. Rosamond W, Flegal K, Furie K, et al. AHA STATISTICAL UPDATE: Heart Disease and Stroke Statistics - 2008 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
4. Palmer AJ, Valentine WJ, Roze S, Lammert M, Spiesser J, Gabriel S. Overview of costs of stroke from published, incidence-based studies spanning 16 industrialized countries. Curr Med Res Opin 2005;21:19-26.
5. Pedelty L, Gorelick PB. Management of hypertension and cerebrovascular disease in the elderly. Am J Med 2008;121:S23-S31.
6. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on stroke: Co-Sponsored by the council on cardiovascular radiology and intervention: The American Academy of Neurology affirms the value of this guideline. Circulation 2006;113:e409-e449.
7. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.
8. Bensley JG, Stacy VK, Matteo RD. Cardiac remodeling as a result of pre-term birth: Implications for future cardiovascular disease. Eur Heart J 2010;31:2058-2066.
9. Rietbrock S, Heeley E, Plumb J, Staa T. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the congestive heart failure, hypertension, age >75, diabetes mellitus, and prior stroke or transient ischemic attack (CHADS2) risk stratification scheme. Am Heart J 2008;156:57-64.
10. Münzel1 T, Gori1 T, Bruno RM, Taddei S. Translational medicine: Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J 2010;31:2741-2748.
11. Lubitz SA, Rosen AB, Ellinor PT, Benjamin EJ. Stroke risk in AF: Do AF patterns matter? Eur Heart J 2010;31:908-910.
12. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: Report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J 2010;31:967-975.
13. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-2429.
14. Romero-Corral A, Somers1 VK, Sierra-Johnson J, et al. Normal weight obesity: A risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 2010;31:737-746.
15. Andersen ZJ, Olsen TS, Andersen KK, Loft S, Ketzel M, Raaschou-Nielsen O. Association between short-term exposure to ultrafine particles and hospital admissions for stroke in Copenhagen, Denmark. Eur Heart J 2010;31:2034-2040.
16. Ducrocq G, Wallace JS, Baron G, et al. Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis. Eur Heart J 2010;31:1257-1265.
17. Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rats (SHR). Circ Res 1974;34:I-143-I-145.
18. Zhang W, Liu AJ, Yi-Ming W, Liu JG, Shen FM, Su DF. Pressor and non-pressor effects of sodium loading on stroke in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2008;35:83-88.
19. Liu AJ, Ma XJ, Shen FM, Liu JG, Chen H, Su DF. Arterial baroreflex. A novel target for preventing stroke in rat hypertension. Stroke 2007;38:1916-1923.
20. Zaremba J, Skrobanski P, Losy J. Tumour necrosis factor-alpha is increased in the cerebrospinal fluid and serum of ischaemic stroke patients and correlates with the volume of evolving brain infarct. Biomed Pharmacother 2001;55:258-263.
21. Yang TH, Chang CY, Hu ML. Various forms of homocysteine and oxidative status in the plasma of ischemic-stroke patients as compared to healthy controls. Clin Biochem 2004;37:494-499.
22. Weeks ME, Sinclair J, Butt A, et al. A parallel proteomic and metabolomic analysis of the hydrogen peroxide- and Sty1p-dependent stress response in Schizosaccharomyces pombe. Proteomics 2006;6:2772-2796.
23. Craig A, Sidaway J, Holmes E, et al. Systems toxicology: Integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat. J Proteome Res 2006;5:1586-1601.
24. Alban A, David SO, Bjorkesten L, et al. A novel experimental design for comparative two-dimensional gel analysis: Two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003;3:36-44.
25. Bredemeyer AJ, Lewis RM, Malone JP, et al. MEDICAL SCIENCES: A proteomic approach for the discovery of protease substrates. PNAS 2004;101:11785-11790.
26. Kaski JC. C-reactive protein improves risk prediction in patients with acute coronary syndrome, or does it? Eur Heart J 2010;31:274-277.
27. El-Kossi MM, Zakhary MM. Oxidative stress in the context of acute cerebrovascular stroke. Stroke 2000;31:1889-1892.
28. Catalá A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem Phys Lipids 2009;157:1-11.
29. Charakida M, Masi S, Lüscher TF. Assessment of atherosclerosis: The role of flow-mediated dilatation. Eur Heart J 2010;31:2854-2861.
30. Heiss C, Keen CL, Kelm M. Flavanols and cardiovascular disease prevention. Eur Heart J 2010;31:2583-2592.
31. Daniel YA, Turner C, Haynes RM, Hunt BJ, Dalton RN. HEMATOLOGY: Quantification of hemoglobin A2 by tandem mass spectrometry. Clin Chem 2007;53:1448-1454.
32. Merril CR, Harrington MG. "Ultrasensitive" silver stains: Their use exemplified in the study of normal human cerebrospinal fluid proteins separated by two-dimensional electrophoresis. Clin Chem 1984;30:1938-1942.
33. Brakch N, Dormond O, Bekri S. Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease. Eur Heart J 2010;31:67-76.
34. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112-119.
35. Schuessel K, Schafer S, Bayer TA, et al. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice. Neurobiol Dis 2005;18:89-99.
36. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271-278.
37. Tonge R, Shaw J, Middleton B, et al. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001;1:377-396.
38. Yousuf S, Atif F, Ahmad M, et al. Selenium plays a modulatory role against cerebral ischemia-induced neuronal damage in rat hippocampus. Brain Res 2007;1147:218-225.
39. Saleem S, Ahmad M, Ahmad AS, et al. Behavioral and histologic neuroprotection of aqueous garlic extract after reversible focal cerebral ischemia. J Med Food 2006;9:537-544.
40. Sun M, Zhao Y, Gu Y, Xu C. Inhibition of nNOS reduces ischemic cell death through down-regulating calpain and caspase-3 after experimental stroke. Neurochem Int 2009;54:339-346.
41. Wang X, Michaelis EK. Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci 2010;2:12-25.
42. Khan MM, Ishrat T, Ahmad A, et al. Sesamin attenuates behavioral, biochemical and histological alterations induced by reversible middle cerebral artery occlusion in the rats. Chem Biol Interact 2010;183:255-263.
43. Reiter RJ, Tan DX, Leon J, Kilic U, Kilic E. When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med (Maywood) 2005;230:104-117.
44. Niizuma K, Endo H, Chan PH. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 2009;109:133-138.
45. Cherubini A, Ruggiero C, Polidori MC, Mecocci P. Potential markers of oxidative stress in stroke. Free Radic Biol Med 2005;39:841-852.